Medicare Enrolled
Dr. Andrea Teague, M.D.
Hematology & Oncology · Albany, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Teague from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Teague?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Teague
Dr. Andrea Teague is a hematology & oncology specialist in Albany, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Teague performed 1,419 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Teague received a total of $22,422 from 72 pharmaceutical and/or device companies across 904 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Teague is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 36% volume in NY
$22,422 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,419
Medicare services
Top 36% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
742 | $94 | $261 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $60 | $169 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
144 | $131 | $372 |
| New patient office visit, complex (60-74 min) | 96 | $158 | $561 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
31 | $94 | $347 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $69 | $129 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $131 | $677 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$22,422
Total received (2018-2024)
Avg $3,203/year across 7 years
Top 17% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
904
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,319
2023
$2,948
2022
$5,609
2021
$1,804
2020
$1,358
2019
$1,051
2018
$1,334
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$2,726
Janssen Scientific Affairs, LLC
$1,470
Stemline Therapeutics Inc.
$1,259
Novartis Pharmaceuticals Corporation
$312
Janssen Biotech, Inc.
$261
PFIZER INC.
$242
Exelixis Inc.
$210
Merck Sharp & Dohme LLC
$168
Mirati Therapeutics, Inc.
$166
E.R. Squibb & Sons, L.L.C.
$154
Incyte Corporation
$117
Eisai Inc.
$96
Gilead Sciences, Inc.
$91
TerSera Therapeutics LLC
$76
Daiichi Sankyo Inc.
$72
BeiGene USA, Inc.
$61
ABBVIE INC.
$60
JAZZ PHARMACEUTICALS INC.
$53
GlaxoSmithKline, LLC.
$52
Kite Pharma, Inc.
$52
Blueprint Medicines Corporation
$50
ARRAY BIOPHARMA INC
$47
Genmab U.S., Inc.
$46
Tempus AI, Inc
$41
Regeneron Healthcare Solutions, Inc.
$37
Pharmacosmos Therapeutics Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$36
Adaptive Biotechnologies Corporation
$29
GENZYME CORPORATION
$27
PUMA BIOTECHNOLOGY, INC.
$25
Alexion Pharmaceuticals, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$23
Karyopharm Therapeutics Inc.
$23
Janssen Pharmaceuticals, Inc
$22
Agios Pharmaceuticals, Inc.
$22
SOBI, INC
$21
Celgene Corporation
$21
Rigel Pharmaceuticals, Inc.
$19
Genentech USA, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
EMD Serono, Inc.
$17
PharmaEssentia USA Corporation
$16
Top 3 companies account for 65.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,563
Janssen Scientific Affairs, LLC
$1,527
E.R. Squibb & Sons, L.L.C.
$1,292
Stemline Therapeutics Inc.
$1,274
Novartis Pharmaceuticals Corporation
$970
Seagen Inc.
$860
Janssen Biotech, Inc.
$761
PFIZER INC.
$761
Exelixis Inc.
$644
Amgen Inc.
$513
Genentech USA, Inc.
$513
Lilly USA, LLC
$495
Incyte Corporation
$495
Merck Sharp & Dohme LLC
$328
Gilead Sciences, Inc.
$320
Celgene Corporation
$318
GENZYME CORPORATION
$318
JAZZ PHARMACEUTICALS INC.
$245
Eisai Inc.
$204
Mirati Therapeutics, Inc.
$204
BeiGene USA, Inc.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$200
Daiichi Sankyo Inc.
$195
Merck Sharp & Dohme Corporation
$189
EMD Serono, Inc.
$144
Kite Pharma, Inc.
$143
Taiho Oncology, Inc.
$141
CTI BioPharma Corp.
$139
PUMA BIOTECHNOLOGY, INC.
$132
Karyopharm Therapeutics Inc.
$131
Bayer HealthCare Pharmaceuticals Inc.
$125
Hologic, LLC
$124
ARRAY BIOPHARMA INC
$124
Rigel Pharmaceuticals, Inc.
$114
SERVIER PHARMACEUTICALS LLC
$110
Puma Biotechnology, Inc.
$109
ABBVIE INC.
$105
Blueprint Medicines Corporation
$97
AbbVie Inc.
$91
GlaxoSmithKline, LLC.
$82
TerSera Therapeutics LLC
$76
Adaptive Biotechnologies Corporation
$74
Bayer Healthcare Pharmaceuticals Inc.
$70
Pharmacosmos Therapeutics Inc.
$70
PharmaEssentia USA Corporation
$66
EUSA Pharma (US) LLC
$58
Regeneron Healthcare Solutions, Inc.
$54
G1 Therapeutics, Inc.
$50
Genmab U.S., Inc.
$46
Kyowa Kirin, Inc.
$45
EISAI INC.
$41
Tempus AI, Inc
$41
Alexion Pharmaceuticals, Inc.
$39
Seattle Genetics, Inc.
$37
Astellas Pharma US Inc
$33
Janssen Pharmaceuticals, Inc
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Pharmacyclics LLC, An AbbVie Company
$25
Deciphera Pharmaceuticals Inc.
$24
Agios Pharmaceuticals, Inc.
$22
SOBI, INC
$21
Servier Pharmaceuticals LLC
$19
Sumitomo Pharma America, Inc.
$18
Acrotech Biopharma Inc.
$18
Sirtex Medical Inc
$17
Heron Therapeutics, Inc.
$15
TAIHO ONCOLOGY, INC.
$15
Myovant Sciences Inc.
$15
Jazz Pharmaceuticals Inc.
$14
Mylan Institutional Inc.
$13
Dova Pharmaceuticals
$12
Array BioPharma Inc.
$12
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cervical Cancer Screening · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Epkinly · Erleada · FASLODEX · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Orserdu · PADCEV · PLUVICTO · POTELIGEO · PROMACTA · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xtandi · YERVOY · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
37
County median income
$83,149
Nearest hospital to ZIP centroid (approximate)
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Teague is a clinical cardiology specialist, with moderate Medicare volume, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Teague experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Teague performed 742 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Teague receive payments from pharmaceutical companies?
Yes. Dr. Teague received a total of $22,422 from 72 companies across 904 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Teague's costs compare to other hematology & oncology specialists in Albany?
Dr. Teague's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Teague) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Albany
Browse hematology & oncology specialists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology